FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 19th, 2017 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of October 13, 2017, between CASI Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL CASI Pharmaceuticals, Inc.Exclusive Agency Agreement • October 19th, 2017 • CASI Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
